The goal of this initiative is to encourage the necessary next stages of development and validation of biomarkers with putative value for use in clinical trials for treatments of the core social deficits of Autism Spectrum Disorder (ASD), including multi-site testing and validation for a specific ‘context of use’ (e.g., diagnostic, enrichment, stratification) as a drug development tool.
from NIMH News Feed http://bit.ly/2Kq0U7T
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment